Works by Wu, Jimin

Results: 110
    1
    2
    3
    4
    5
    6

    Venous thromboembolism (VTE) and glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 124, n. 1, p. 87, doi. 10.1007/s11060-015-1805-2
    By:
    • Yust-Katz, Shlomit;
    • Mandel, Jacob;
    • Wu, Jimin;
    • Yuan, Ying;
    • Webre, Courtney;
    • Pawar, Tushar;
    • Lhadha, Harshad;
    • Gilbert, Mark;
    • Armstrong, Terri
    Publication type:
    Article
    7
    8
    9

    Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab.

    Published in:
    Oncologist, 2020, v. 25, n. 6, p. e909, doi. 10.1634/theoncologist.2018-0611
    By:
    • Kogawa, Takahiro;
    • Fujii, Takeo;
    • Wu, Jimin;
    • Harano, Kenichi;
    • Fouad, Tamer M.;
    • Liu, Diane D.;
    • Shen, Yu;
    • Masuda, Hiroko;
    • Krishnamurthy, Savitri;
    • Chavez‐MacGregor, Mariana;
    • Lim, Bora;
    • Murthy, Rashmi K.;
    • Valero, Vicente;
    • Tripathy, Debu;
    • Ueno, Naoto T.
    Publication type:
    Article
    10
    11
    12

    High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.

    Published in:
    Oncologist, 2016, v. 21, n. 1, p. 21, doi. 10.1634/theoncologist.2015-0101
    By:
    • Kogawa, Takahiro;
    • Fouad, Tamer M.;
    • Liu, Diane D.;
    • Wu, Jimin;
    • Shen, Yu;
    • Masuda, Hiroko;
    • Fujii, Takeo;
    • Chavez‐MacGregor, Mariana;
    • Alvarez, Ricardo H.;
    • Hortobágyi, Gabriel N.;
    • Valero, Vicente;
    • Ueno, Naoto T.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.

    Published in:
    2019
    By:
    • Lim, Bora;
    • Murthy, Rashmi K.;
    • Lee, Jangsoon;
    • Jackson, Summer A.;
    • Iwase, Toshiaki;
    • Davis, Darren W.;
    • Willey, Jie S.;
    • Wu, Jimin;
    • Shen, Yu;
    • Tripathy, Debu;
    • Alvarez, Ricardo;
    • Ibrahim, Nuhad K.;
    • Brewster, Abenaa M.;
    • Barcenas, Carlos H.;
    • Brown, Powel H.;
    • Giordano, Sharon H.;
    • Moulder, Stacy L.;
    • Booser, Daniel J.;
    • Moscow, Jeffrey A.;
    • Piekarz, Richard
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26
    27
    28

    Symptom Management and Supportive Care. The Opioid Rotation Ratio of Hydrocodone to Strong Opioids in Cancer Patients.

    Published in:
    Oncologist, 2014, v. 19, n. 11, p. 1185, doi. 10.1634/theoncologist.2014-0130
    By:
    • Reddy, Akhila;
    • Yennurajalingam, Sriram;
    • Desai, Hem;
    • Reddy, Suresh;
    • Cruz, Maxine;
    • Wu, Jimin;
    • Liu, Diane;
    • Rodriguez, Eden Mae;
    • Waletich, Jessica;
    • Shin, Seong Hoon;
    • Gayle, Vicki;
    • Patel, Pritul;
    • Dalal, Shalini;
    • Vidal, Marieberta;
    • Tanco, Kimberson;
    • Arthur, Joseph;
    • Tallie, Kimmie;
    • Williams, Janet;
    • Silvestre, Julio;
    • Bruera, Eduardo
    Publication type:
    Article
    29

    Patterns of Storage, Use, and Disposal of Opioids Among Cancer Outpatients.

    Published in:
    Oncologist, 2014, v. 19, n. 7, p. 780, doi. 10.1634/theoncologist.2014-0071
    By:
    • Reddy, Akhila;
    • Cruz, Maxine;
    • Rodriguez, Eden Mae;
    • Thames, Jessica;
    • Wu, Jimin;
    • Chisholm, Gary;
    • Liu, Diane;
    • Frisbee‐Hume, Susan;
    • Yennurajalingam, Sriram;
    • Hui, David;
    • Cantu, Hilda;
    • Marin, Alejandra;
    • Gayle, Vicki;
    • Shinn, Nancy;
    • Xu, Angela;
    • Williams, Janet;
    • Bruera, Eduardo
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 10, p. 1505, doi. 10.1093/neuonc/noaa062
    By:
    • Puduvalli, Vinay K;
    • Wu, Jing;
    • Yuan, Ying;
    • Armstrong, Terri S;
    • Vera, Elizabeth;
    • Wu, Jimin;
    • Xu, Jihong;
    • Giglio, Pierre;
    • Colman, Howard;
    • Walbert, Tobias;
    • Raizer, Jeffrey;
    • Groves, Morris D;
    • Tran, David;
    • Iwamoto, Fabio;
    • Avgeropoulos, Nicholas;
    • Paleologos, Nina;
    • Fink, Karen;
    • Peereboom, David;
    • Chamberlain, Marc;
    • Merrell, Ryan
    Publication type:
    Article